Smith Mark Douglas

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$28,312.00
Insider Sells Quantity
9
Insider Sells Sum
$1.59M

Insider Activity of Smith Mark Douglas

According to the SEC Form 4 filings, Smith Mark Douglas, being in a position of

  1. director at Jazz Pharmaceuticals plc,
    оver the last 12 months, has bought 0 shares, and sold 417 shares for $49,736,
    over all time since 2021-12-02, has bought 0 shares, and sold 3584 shares for $502,617.

The largest purchase of all time was on 2024-08-15 and amounted to 4000 shares of Teladoc Health, Inc. for $28,312.

The largest sale of all time was on 2021-01-04 and amounted to 12000 shares of Phreesia, Inc. for $483,197.

Biography of Smith Mark Douglas

No biography is available at this moment.

2024-08-15PurchaseTeladoc Health, Inc.
TDOC
director
4,000
0.0024%
$7.08$28,3120%
2024-07-18SalePhreesia, Inc.
PHR
director
7,000
0.0135%
$25.00$175,000+0.44%
2023-12-04SaleJazz Pharmaceuticals plc
JAZZ
director
417
0.0007%
$119.27$49,736-5.74%
2023-08-14SaleJazz Pharmaceuticals plc
JAZZ
director
1,241
0.0019%
$138.16$171,454-13.48%
2023-04-03SalePhreesia, Inc.
PHR
director
7,000
0.0133%
$30.77$215,367-17.13%
2022-12-02SaleJazz Pharmaceuticals plc
JAZZ
director
420
0.0007%
$154.68$64,966-13.69%
2022-08-05SaleJazz Pharmaceuticals plc
JAZZ
1,089
0.0017%
$152.32$165,879-6.46%
2021-12-02SaleJazz Pharmaceuticals plc
JAZZ
director
417
0.0007%
$121.30$50,582+21.6%
2021-01-04SalePhreesia, Inc.
PHR
director
12,000
0.0206%
$40.27$483,197+16.32%
2020-08-10SalePhreesia, Inc.
PHR
director
12,000
0.0178%
$17.51$210,085+72.03%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.